Lv1
16 积分 2022-10-18 加入
Nanomedicines Based on Responsive Nanocarriers for Cancer Therapy
8天前
已完结
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia
29天前
已完结
Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists
29天前
已完结
A Single Institutional Experience Using Avatrombopag to Manage Severe and Refractory Treatment Related Thrombocytopenia in Solid Tumor and Hematologic Malignancy Patients
29天前
已完结
A Single Institutional Experience Using Avatrombopag to Manage Severe and Refractory Treatment Related Thrombocytopenia in Solid Tumor and Hematologic Malignancy Patients
29天前
已关闭
A Single Institutional Experience Using Avatrombopag to Manage Severe and Refractory Treatment Related Thrombocytopenia in Solid Tumor and Hematologic Malignancy Patients
29天前
已关闭
A retrospective cohort study of hetrombopag combined with recombinant human thrombopoietin in the treatment of thrombocytopenia due to antineoplastic therapy[J]. J Clin Hematol, 2024, 37(11): 794-798
29天前
已关闭
Real-World Evidence of Hetrombopag for Cancer Therapy-Induced Thrombocytopenia Among Patients with Gynecologic Malignancies
29天前
已关闭
Real-World Evidence of Hetrombopag for Cancer Therapy-Induced Thrombocytopenia Among Patients with Gynecologic Malignancies
29天前
已关闭
Real-World Evidence of Hetrombopag for Cancer Therapy-Induced Thrombocytopenia Among Patients with Gynecologic Malignancies
29天前
已关闭
皖公网安备34019202002308
